+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Wearable Injectors Market by Type (On-Body and Off-Body injectors (Infusion Pump Devices)), Therapy (Immuno-oncology, Diabetes, Cardiovascular Diseases, Parkinson's Disease, Thalassemia, Primary Immunodeficiency Disease) - Global Forecast to 2023

  • ID: 4655686
  • Report
  • Region: Global
  • 105 Pages
  • Markets and Markets
1 of 5
The Wearable Injectors Market is Projected to Grow at a CAGR of 11.1% During the Forecast Period

FEATURED COMPANIES

  • Amgen
  • Enable Injections
  • Insulet Corporation
  • Medtronic PLC
  • Steadymed Therapeutics
  • Valeritas, Inc.
  • MORE

The global wearable injectors market is projected to reach USD 9.41 billion by 2023 from an estimated USD 5.57 billion in 2018, at a CAGR of 11.1% during the forecast period. The growing prevalence of targeted therapies, favorable reimbursement, and technological advancements in wearable injectors are expected to drive the growth of the wearable injectors market. However, the preference for alternative routes of drug delivery such as pens & autoinjectors is expected to restrain the growth of this market to a certain extent.

Based on type, the market is segmented into on-body and off-body injectors. The off-body injectors segment is expected to register the highest CAGR during the forecast period. The drawbacks associated with on-body wearable injectors, such as painful removal, skin sensitivity issues and irritation, and adhesive fitting issues have resulted in the increased demand for off-body injectors.
Based on therapy, the global wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (Parkinson’s Disease, thalassemia, and primary immunodeficiency disorders). The cardiovascular diseases segment is expected to witness the highest CAGR during the forecast period. The high growth of the segment can be primarily attributed to the high burden of CVDs across the globe coupled with the growing availability of wearable injectors for the treatment of CVDs.

North America is expected to witness the highest growth from 2018 to 2023. This can be attributed to the rising prevalence of chronic diseases in the US and Canada; favorable reimbursement scenarios; and an increasing number of awareness programs in the US and Canada.

Breakup of primary participants is mentioned below:

  • By Company Type: Tier 1 - 55%, Tier 2 - 25%, and Tier 3 - 20%
  • By Designation: C-level - 43%, Director-level - 32%, and Others–25%
  • By Region: North America - 38%, Europe - 23%, Asia Pacific - 29%, and the Row–10%

The key players in the global wearable injectors market are Amgen (US), Medtronic (Ireland), Insulet Corporation (US), Tandem Diabetes Care (US), United Therapeutic Corporation (US), Valeritas (US), SteadyMed Therapeutics (US), Ypsomed (Switzerland), Becton, Dickinson and Company (US), Enable Injections (US), Sensile Medicals (Switzerland), and Bespak (UK).

Research Coverage
The report analyzes the wearable injectors market and aims at estimating the market size and future growth potential of this market based on various segments such as type, therapy, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy
The report can help established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them garner a greater share. Firms purchasing the report could use one or any combination of the below mentioned five strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the wearable injectors market. The report analyzes the market based on type, therapy, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the wearable injectors market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various wearable injectors across regions
  • Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the wearable injectors market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the market
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Amgen
  • Enable Injections
  • Insulet Corporation
  • Medtronic PLC
  • Steadymed Therapeutics
  • Valeritas, Inc.
  • MORE

1 Introduction
1.1 Objectives of Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Wearable Injectors Market: Overview
4.2 Global Market, By Type, 2018 vs 2023
4.3 Geographic Analysis: Global Market, By Therapy
4.4 Geographic Snapshot: Global Market

5 Wearable Injectors Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Prevalence of Chronic Diseases
5.2.1.2 Favorable Reimbursement Scenario in Major Markets
5.2.1.3 Technological Advancements and Design Development
5.2.2 Restraints
5.2.2.1 Preference for Alternative Drug Delivery Modes
5.2.3 Opportunities
5.2.3.1 Increasing Demand for Biologics and MABS
5.2.4 Challenges
5.2.4.1 Unfavorable Reimbursement Structure in Developing Countries

6 By Type
6.1 Introduction
6.2 On-Body Injectors
6.3 Off-Body Injectors

7 By Therapy
7.1 Introduction
7.2 Immuno-Oncology
7.3 Diabetes
7.4 Cardiovascular Diseases
7.5 Other Therapies

8 By Region
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 RoAPAC
8.5 Rest of the World

9 Competitive Landscape
9.1 Overview
9.2 Market Share Analysis
9.3 Market Share Analysis, By Therapy
9.3.1 Immuno-Oncology
9.3.2 Amgen
9.3.3 Diabetes
9.3.4 Medtronic
9.3.5 Insulet Corporation
9.3.6 Cardiovascular Diseases
9.3.7 United Therapeutics
9.4 Competitive Scenario
9.4.1 Product Launches and Approvals
9.4.2 Expansions
9.4.3 Agreements, Collaborations, and Partnerships

10 Company Profiles
10.1 Amgen
10.2 Medtronic PLC
10.3 Insulet Corporation
10.4 Ypsomed
10.5 Becton, Dickinson and Company
10.6 Tandem Diabetes Care, Inc.
10.7 United Therapeutics Corporation
10.8 Valeritas, Inc.
10.9 Enable Injections
10.10 Steadymed Therapeutics
10.11 Sensile Medical (A Part of Gerresheimer)

List of Tables
Table 1 Wearable Injectors (WI) Market, By Type, 2016–2023 (USD Billion)
Table 2 On-Body WI Market, By Country, 2016–2023 (USD Million)
Table 3 Off-Body WI Market, By Country, 2016–2023 (USD Million)
Table 4 Global Market, By Therapy, 2016–2023 (USD Billion)
Table 5 Global Market for Immuno-Oncology, By Country, 2016–2023 (USD Million)
Table 6 Insulin Devices Available for Diabetic Patients
Table 7 Global Market for Diabetes, By Country, 2016–2023 (USD Million)
Table 8 Global Market for Cardiovascular Diseases, By Country, 2016–2023 (USD Million)
Table 9 Global Market for Other Therapies, By Country, 2016–2023 (USD Million)
Table 10 Global Market, By Region, 2016-2023 (USD Million)
Table 11 North America: Wearable Injectors Market, By Country, 2016-2023 (USD Million)
Table 12 North America: Market, By Therapy, 2016-2023 (USD Million)
Table 13 North America: Market, By Type, 2016-2023 (USD Million)
Table 14 US: Market, By Therapy, 2016-2023 (USD Million)
Table 15 US: Market, By Type, 2016-2023 (USD Million)
Table 16 Canada: Market, By Therapy, 2016-2023 (USD Million)
Table 17 Canada: Market, By Type, 2016-2023 (USD Million)
Table 18 Recent Developments in the Wearable Injectors Market in Europe, 2015–2018
Table 19 Europe: Market, By Country, 2016-2023 (USD Million)
Table 20 Europe: Market, By Therapy, 2016-2023 (USD Million)
Table 21 Europe: Market, By Type, 2016-2023 (USD Million)
Table 22 Germany: Market, By Therapy, 2016-2023 (USD Million)
Table 23 Germany: Market, By Type, 2016-2023 (USD Million)
Table 24 UK: Market, By Therapy, 2016-2023 (USD Million)
Table 25 UK: Market, By Type, 2016-2023 (USD Million)
Table 26 France: Wearable Injectors Market, By Therapy, 2016-2023 (USD Million)
Table 27 France: Market, By Type, 2016-2023 (USD Million)
Table 28 RoE: Market, By Therapy, 2016-2023 (USD Million)
Table 29 RoE: Market, By Type, 2016-2023 (USD Million)
Table 30 Asia Pacific: Market, By Country, 2016-2023 (USD Million)
Table 31 Asia Pacific: Market, By Therapy, 2016-2023 (USD Million)
Table 32 Asia Pacific: Market, By Type, 2016-2023 (USD Million)
Table 33 Japan: Wearable Injectors Market, By Therapy, 2016-2023 (USD Million)
Table 34 Japan: Market, By Type, 2016-2023 (USD Million)
Table 35 China: Market, By Therapy, 2016-2023 (USD Million)
Table 36 China: Market, By Type, 2016-2023 (USD Million)
Table 37 India: Market, By Therapy, 2016-2023 (USD Million)
Table 38 India: Market, By Type, 2016-2023 (USD Million)
Table 39 RoAPAC: Market, By Therapy, 2016-2023 (USD Million)
Table 40 RoAPAC: Wearable Injectors Market, By Type, 2016-2023 (USD Million)
Table 41 Conferences in Africa, Brazil, and the Middle East (2016–2018)
Table 42 RoW: Market, By Therapy, 2016-2023 (USD Million)
Table 43 RoW: Market, By Type, 2016-2023 (USD Million)
Table 44 Product Launches and Approvals
Table 45 Expansions
Table 46 Agreements, Collaborations, and Partnerships

List of Figures
Figure 1 Wearable Injectors Market: Research Methodology Steps
Figure 2 Break Down of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Research Design
Figure 6 Data Triangulation Methodology
Figure 7 Immuno-Oncology Therapy Segment to Dominate the Wearable Injectors Market in 2018
Figure 8 On-Body Injectors to Account for the Largest Share of the Global Market in 2018
Figure 9 North America to Witness the Highest Market Growth During the Forecast Period
Figure 10 Growing Prevalence of Chronic Diseases is Driving Market Growth
Figure 11 On-Body Injectors Segment to Dominate the Market in 2018
Figure 12 Immuno-Oncology Segment to Command the Largest Share of the Market in 2018
Figure 13 North America to Witness the Highest Growth Rate During the Forecast Period
Figure 14 Wearable Injectors Market: Drivers, Restraints, Opportunities, & Challenges
Figure 15 Global Market, By Type, 2018 vs 2023 (USD Billion)
Figure 16 Wearable Injectors Market, By Therapy, 2018 vs 2023 (USD Billion)
Figure 17 North America to Command the Largest Market Share in 2018
Figure 18 North America: Market Snapshot
Figure 19 Europe: Market Snapshot
Figure 20 Asia Pacific: Market Snapshot
Figure 21 RoW: Market Snapshot
Figure 22 Strategies Adopted By Market Players (2014–2018)
Figure 23 Amgen: Company Snapshot (2017)
Figure 24 Medtronic PLC: Company Snapshot (2017)
Figure 25 Insulet Corporation: Company Snapshot (2017)
Figure 26 Ypsomed: Company Snapshot (2017)
Figure 27 BD: Company Snapshot (2017)
Figure 28 Tandem Diabetes Care: Company Snapshot (2017)
Figure 29 United Therapeutics Corporation: Company Snapshot (2017)
Figure 30 Valeritas: Company Snapshot (2017)

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
5 of 5
  • Amgen
  • Becton, Dickinson and Company
  • Enable Injections
  • Insulet Corporation
  • Medtronic PLC
  • Sensile Medical (A Part of Gerresheimer)
  • Steadymed Therapeutics
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Valeritas, Inc.
  • Ypsomed
Note: Product cover images may vary from those shown
Adroll
adroll